Skip to main content
Livermore
Livermore
ZHEN

Waters Parkerson & Co., LLC

SEC CIK
0001222993
Latest filing
Jul 30, 2026

GSK holding history

GSK plc in every 13F filed by Waters Parkerson & Co., LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
5,034
Value
$263.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Waters Parkerson & Co., LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,034$263.9K<0.1%−70−1.4%ReducedHolders
Q1 20265,104$281.7K<0.1%00.0%UnchangedHolders
Q4 20255,104$250.3K<0.1%00.0%UnchangedHolders
Q3 20255,104$220.3K<0.1%−8,140−61.5%ReducedHolders
Q2 202513,244$508.6K<0.1%−1,200−8.3%ReducedHolders
Q1 202514,444$559.6K<0.1%−1,694−10.5%ReducedHolders
Q4 202416,138$545.8K<0.1%00.0%UnchangedHolders
Q3 202416,138$660.0K<0.1%−2,642−14.1%ReducedHolders
Q2 202418,780$723.0K<0.1%+962+5.4%AddedHolders
Q1 202417,818$764.0K<0.1%−52−0.3%ReducedHolders
Q4 202317,870$662.0K<0.1%−660−3.6%ReducedHolders
Q3 202318,530$672.0K<0.1%+550+3.1%AddedHolders
Q2 202317,980$641.0K<0.1%00.0%UnchangedHolders
Q1 202317,980$640.0K<0.1%−728−3.9%ReducedHolders
Q4 202218,708$657.0K<0.1%−2,425−11.5%ReducedHolders
Q3 202221,133$622.0K<0.1%−5,774−21.5%ReducedHolders
Q2 202226,907$1.17M0.1%−393−1.4%ReducedHolders
Q1 202227,300$1.19M0.1%−1,916−6.6%ReducedHolders
Q4 202129,216$1.29M0.1%+63+0.2%AddedHolders
Q3 202129,153$1.11M0.1%−1,484−4.8%ReducedHolders
Q2 202130,637$1.22M0.1%−87,090−74.0%ReducedHolders
Q1 2021117,727$4.20M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.